Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders: Baseline Results From the RAISE-ETP Study

Study Questions:

What is the cardiometabolic risk in first-episode schizophrenia spectrum disorders (FES) and its relationship to illness duration; antipsychotic treatment duration; and type, sex, and race/ethnicity?